Drug Insight: immunomodulatory effects of statins—potential benefits for renal patients?-Reference-Cited by-同舟云学术

Drug Insight: immunomodulatory effects of statins—potential benefits for renal patients?

Published:2006-07 Issue:7 Volume:2 Page:378-387
ISSN:1745-8323
Container-title:Nature Clinical Practice Nephrology
language:en
Short-container-title:Nat Rev Nephrol

Author:

Steffens Sabine,Mach François

Publisher

Springer Science and Business Media LLC

Subject

Nephrology,General Medicine

Link

http://www.nature.com/articles/ncpneph0217.pdf

Reference108 articles.

1. LaRosa JC (2002) What do the statins tell us? Am Heart J 144 (Suppl): S21–S26

2. LaRosa JC et al. (1999) Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA 282: 2340–2346

3. Athyros VG et al. (2002) Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study. Curr Med Res Opin 18: 220–228

4. [No authors listed] (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344: 1383–1389

5. [No authors listed] (1998) Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels: the Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med 339: 1349–1357

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gut Dysbiosis and Immune System in Atherosclerotic Cardiovascular Disease (ACVD);Microorganisms;2022-01-05

2. MECHANISMS OF ATHEROGENESIS AND ITS INTENSIFICATION IN PATIENTS WITH RHEUMATOID ARTHRITIS;Likarska sprava;2020-12-30

3. Post Kidney Transplant: Cardiovascular Complications;Kidney Transplant Management;2018-10-31

4. Nanoplumbers: biomaterials to fight cardiovascular diseases;Materials Today;2018-03

5. Inhibition of the mevalonate pathway by simvastatin interferes with mast cell degranulation by disrupting the interaction between Rab27a and double C2 alpha proteins;European Journal of Pharmacology;2017-11